Extracellular microvesicle micro RNA s in children with sickle cell anaemia with divergent clinical phenotypes

Summary Sickle cell anaemia ( SCA ) is the most frequent genetic haemoglobinopathy, which exhibits a highly variable clinical course characterized by hyper‐coagulable and pro‐inflammatory states, as well as endothelial dysfunction. Extracellular microvesicles are released into biological fluids and play a role in modifying the functional phenotype of target cells. We hypothesized that potential differences in plasma‐derived extracellular microvesicles ( EV ) function and cargo from SCA patients may underlie divergent clinical trajectories. Plasma EV from SCA patients with mild, intermediate and severe clinical disease course were isolated, and primary endothelial cell cultures were exposed. Endothelial cell activation, monocyte adhesion, barrier disruption and exosome cargo (micro RNA microarrays) were assessed. EV disrupted the endothelial barrier and induced expression of adhesion molecules and monocyte adhesion in a SCA severity‐dependent manner compared to healthy children. Microarray approaches identified a restricted signature of exosomal micro RNA s that readily distinguished severe from mild SCA , as well as from healthy children. The micro RNA candidates were further validated using quantitative real time polymerase chain reaction assays, and revealed putative gene targets. Circulating exosomal micro RNA s may play important roles in predicting the clinical course of SCA , and in delineation of individually tailored, mechanistically‐based clinical treatment approaches of SCA patients in the near future.